Drug class in one race
PPAR-gamma drugs for Type 2 Diabetes
3 tracked PPAR-gamma drugs in the Type 2 Diabetes race. The class explanation lives on the PPAR-gamma page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
1 approved / phase 42 Phase 3
Head-to-head evidence: JT-001 vs Lobeglitazone · JT-001 vs Rosiglitazone · Lobeglitazone vs Rosiglitazone